Evolent Health EVH
NYSE EVH
$4.32 +0.05 (+1.17%)
At close: Sep 4, 2026 · 4:00 PM EDT

Evolent Health (EVH) Notes Payables (2023 - 2025)

Evolent Health (EVH) posted Notes Payables of $5.1 million for Q3 2025, down 97.03% on a QoQ basis from $172.1 million in Q2 2025.

Analysis

Evolent Health (EVH) Notes Payables (2023 - 2025) Analysis & Trends

Evolent Health has reported Notes Payables for 3 years, with the latest figure at $5.1 million in Q3 2025.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $5.1 million in Q3 2025; TTM through Sep 2025 was $5.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $171.5 million, changed N/A from the prior year.
  • Notes Payables was $5.1 million for Q3 2025 at Evolent Health, down from $172.1 million in the prior quarter.
  • The five-year high for Notes Payables was $172.1 million in Q2 2025, with the low at $991000.0 in Q3 2023.
  • Average Notes Payables over 3 years is $104.3 million, with a median of $171.5 million recorded in 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.76 Bn 12.64 Bn 1.16 Bn
2 RadNet 5.80 Bn 5.37 Bn 88.08 Mn
3 Concentra Group Holdings Parent 4.40 Bn 4.26 Bn 192.10 Mn
4 Privia Health 2.61 Bn 2.25 Bn -
5 Pediatrix Medical 2.20 Bn 1.79 Bn -
6 Fresenius Medical Care AG 2.11 Bn 1.41 Bn 1.52 Bn
7 Progyny 2.01 Bn 1.77 Bn 89.30 Mn
8 Surgery Partners 1.87 Bn 3.08 Bn 622.10 Mn
9 U S Physical Therapy 1.18 Bn 1.47 Bn 41.94 Mn
10 Evolent Health 488.42 Mn 346.95 Mn 80.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.12 Mn
Jun 30, 2025 172.12 Mn
Mar 31, 2025 171.79 Mn
Dec 31, 2024 171.47 Mn
Sep 30, 2023 991,000.00